News & Blog

Tag Archives: FDA

Advice Column, April 2018: Exploring Novel Brain Tumor Treatments

National Brain Tumor Society recently announced the launch of a new patient and care-partner education, empowerment, and preparedness effort. The new initiative will provide the resources, information, tools, and guidance brain tumor patients and their care-partners need to play a more active role in their treatment planning and decision-making. As part of the broader effort to […]

March 2018 Public Policy and Advocacy Updates

For a number of years now, our Public Policy & Advocacy staff have put out monthly emails to those who’ve signed-up to be NBTS volunteer advocates, providing updates on the latest goings-on in the world of brain tumor public policy and issues related to legislation that impacts this community. As our advocacy program continues to […]

Glossary Blog, February 2018: CAR T-Cell Therapy

CAR T-cell Therapy: A type of treatment in which a patient’s T-cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T-cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is […]

Share